MH acted for Redalpine on their investment into London-based AI medical imaging startup Hypervision Surgical on its oversubscribed seed round.
The King’s College London spinout is developing medical imaging for surgery by harnessing AI hyperspectral imaging and edge computing.
Surgeons using the new MedTech software can view tissue perfusion which cannot be seen by the eye.
Redalpine is a Swiss VC that empowers game changers. Since 2006, the firm has backed over 85 companies through seven funds. It has invested in some of Europe’s most ambitious startups, guiding companies from early-stage to market leaders. Redalpine’s mission statement aligns with Marriott Harrison’s commitment to working alongside companies that shape the future.